在ACS中,在CABG后,阿司匹林单疗法或DAPT? 来自TACSI试验的洞察力
1Department of Cardiac Surgery, Rabindranath Tagore International Institute of Cardiac Sciences, Narayana Health, 124, EM Bypass, Mukundapur, India.
Indian journal of thoracic and cardiovascular surgery
|November 24, 2025
概括
双重抗血小板治疗 (Ticagrelor加阿司匹林) 与单独的阿司匹林相比,在冠状动脉旁路移植后,急性冠状动脉综合征患者的结果没有改善. 然而,它显著增加了严重出血的风险.
科学领域:
- 心脏病学 心脏病学
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- 双抗血小板治疗 (DAPT) 是标准的后急性冠状动脉综合征 (ACS).
- 在冠状动脉旁路移植 (CABG) 患者中DAPT的证据有限.
- 目前的指导方针建议在ACS后使用DAPT,而不管重血管化策略如何.
研究的目的:
- 为了评估DAPT (蒂卡格勒加阿司匹林) 与单独阿司匹林的疗效和安全性,在接受单独CABG的ACS患者中.
- 为了确定DAPT是否在这个特定的患者群体中提供超出阿司匹林单一治疗的额外好处.
主要方法:
- 在TACSI试验中,随机选择了2201名接受隔离CABG的ACS患者.
- 患者接受了Ticagrelor加阿司匹林或仅用阿司匹林一年的治疗.
- 评估的结果包括死亡,心肌梗塞,中风和重复的血管化.
主要成果:
- 与单独服用阿司匹林在一年后相比,提卡格雷勒加阿司匹林并没有显著降低死亡,心肌梗塞,中风或重复复血管化的复合终点.
- 在DAPT组中,严重出血的风险增加了近两倍.
- 与阿司匹林添加蒂卡格勒洛尔时没有观察到任何显著的益处.
结论:
- 与单独的阿司匹林相比,DAPT与提卡格雷勒和阿司匹林一起使用在隔离的CABG后对ACS患者没有提供额外的益处.
- 在这个人群中,DAPT增加了大出血的风险,这挑战了其常规使用.
- 结果表明,在ACS被证明是合理后,对患者进行CABG后的DAPT建议进行重新评估.
相关概念视频
01:28Acute Coronary Syndrome IV: Interprofessional Care
203
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
203
01:27Coronary Artery Disease V: Interprofessional Care
206
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
206
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.1K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.1K
01:26Angina IV: Management
222
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
222
01:27Peripheral Artery Disease III: Interprofessional Care
229
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
229
01:26Acute Coronary Syndrome V: Nursing Management
253
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
253